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stable and unstable acute neurologic deﬁcits
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Daniela Mazzaccaro, MD,a Alberto M. Settembrini, MD,a Raffaello Dallatana, MD,a and
Piergiorgio G. Settembrini, MD,a,c Milan, Italy
Objective: The aim of the study was to assess the outcomes of carotid endarterectomy (CEA) performed in an urgent
setting on acutely symptomatic patients selected through a very simple protocol.
Methods: From January 2002 to January 2012, 193 symptomatic patients underwent CEA. Of these, 90 presented with
acute symptoms, and after a congruous carotid stenosis was identiﬁed, underwent urgent operations (group 1): 27
patients had transient ischemic attack (group 1A), 52 patients had mild to moderate stroke (group 1B), and 11 patients
had stroke in evolution (group 1C). The remaining 103 patients with a nonrecent neurologic deﬁcit were treated by
elective surgery in the same period (group 2). End points were 30-day neurologic morbidity and mortality.
Results: The median delay of urgent CEA (U-CEA) from deﬁcit onset was 48 hours (interquartile range, 13-117 hours).
Groups 1 and 2 were comparable in demographics. Acute patients showed a higher rate of stroke at presentation (70%
vs 37%; P [ .001) and of history of coronary artery disease (30% vs 13.5%; P [ .007). Acute patients sustained six
postoperative strokes (6.6%). Neurologic outcomes were correlated to clinical presentation: no strokes occurred in group
1A patients, and 5.8% group 1B patients and 27.3% group 1C patients had postoperative stroke (P < .01). Postoperative
mortality was 4.4% for U-CEA: one fatal myocardial infarction, one intracranial hemorrhage, and two thromboembolic
strokes. Elective patients sustained four postoperative strokes (3.9%), with one death (0.9%) as a consequence of
hyperperfusion cerebral edema. U-CEAs performed #48 hours from symptom onset had a lower postoperative stroke
rate than those performed >48 hours (4.4% vs 8.8%; P [ .3). Among patients presenting with a stroke (group 1B), the
National Institutes of Health Stroke Scale (NIHSS) assessment at discharge showed improvement in 79% (although
only 25% had $4 points in reduction), stability in 17%, and deterioration in 4%. Patients with moderate stroke were
slightly better in NIHSS improvement than those with mild stroke (median NIHSS variation at discharge, L3 vs L1;
P [ .001).
Conclusions: Our results with U-CEA conﬁrm that this population has a higher risk proﬁle compared with elective
surgery. The type of acute presentation is correlated with perioperative risk. U-CEA was safe when performed on patients
presenting with transient ischemic attack. An acceptable complication rate was achieved for patients with minor to
moderate strokes. The poorest outcomes occurred in patients presenting with stroke in evolution: U-CEA in these
patients should be offered with extreme caution, although we are aware that a conservative treatment may not grant
a better prognosis. (J Vasc Surg 2014;59:440-6.)At the beginning of the 1990s, large international
randomized trials1-3 demonstrated that elective carotid
endarterectomy (CEA) is an effective intervention for
patients with symptomatic carotid stenosis. In the
mid-2000s, a pooled analysis of data from the North
American Symptomatic Carotid Surgery Trial (NAS-
CET) and European Carotid Surgery Trial showed
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on >14 days.4-6
Despite recent guidelines recommending CEA within
this time frame,7-9 debate on the timing of CEA is still open.
There is the possibility that amore expedited approach (emer-
gent/urgent CEA) might increase CEA effectiveness and
minimize the rate of ischemic recurrence.However, deﬁnitive
data are lacking on the risks of treating patients with cerebro-
vascular accidents (CVAs) in the hyperacute phase, sometimes
before stabilization of symptoms. The aim of this study was to
review our series of CEA performed on acute symptomatic
patients since a Stroke Unit was opened in our hospital.
METHODS
Study design. We retrospectively reviewed a cohort of
patients selected by a protocol aiming at reducing the risk
of stroke10-12 or stroke recurrence13-15 for patients pre-
senting in our hospital with an acute onset of a neurologic
deﬁcit. This protocol was set in 2002 when the Stroke Unit
opened. We also retrospectively reviewed all patients who
underwent elective CEA in the same period of time
(January 2002 to January 2012).
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medications, clinical presentation, radiologic ﬁndings at
admission and at discharge, timing of surgery, operative
details, complications, and follow-up. Primary outcomes
were 30-day postoperative strokes, 30-day postoperative
mortality, and combined 30-day death/stroke rate.
Outcomes of urgently operated-on patients were further
stratiﬁed according to their clinical presentation and to
the timing of surgery from symptom onset.
Deﬁnitions. We deﬁned a single transient ischemic
attack (TIA) as a focal neurologic deﬁcit lasting#24 hours,
and recurrent TIAs were recurrent episodes of neurologic
deﬁcit all lasting #24 hours. Minor stroke was deﬁned as
stroke ranging from 1 to 4 on the National Institutes of
Health Stroke Scale (NIHSS), moderate stroke was deﬁned
as a stroke ranging from 5 to 15 on the NHISS, and stroke
in evolution (SIE) was deﬁned as a stroke with progression
or ﬂuctuation of neurologic deﬁcit while the patient was
under observation.
Postoperative hemorrhagic stroke was deﬁned as
appearance of a new hemorrhagic lesion on brain
computed tomography (bCT). Postoperative ischemic
stroke was deﬁned as expansion of a preoperative lesion
or appearance of new ischemic lesions on bCT, when asso-
ciated with nontransitory progression of NIHSS. Postoper-
ative hyperperfusion syndrome was deﬁned as the
appearance of diffused brain edema on bCT associated
with headache or seizures in presence of postoperative
hypertension.
Emergency diagnostic workup. After blood tests and
an electrocardiogram, a neurologic evaluation is immedi-
ately performed by a neurologist. In case of a TIA, the
risk of progression to stroke by the ABCD2 assessment
(age, blood pressure [BP], clinical features of the TIA,
duration of symptoms, and diabetes mellitus)16 is calcu-
lated. The grade of neurologic deﬁcit is established by the
NIHSS.17 A bCT is routinely obtained to rule out intra-
cranial hemorrhage. If no sign of hemorrhage or massive
stroke is detected on bCT and the NIHSS is #15 without
loss or severe alteration of conscience, patients are referred
to the vascular surgeon for urgent carotid ultrasound
imaging.
The carotid duplex scan is performed by vascular
surgeons (case load $200 carotid duplex scans per
physician per year) and it is available from 8:00 am to
8:00 pm every day. If a patient is admitted during the night,
the screening carotid ultrasound assessment is performed by
the neurologist on the ward. If the result is positive for
echographic signs of plaque or stenosis, a conﬁrmatory
examination is immediately performed by the vascular
surgeon on call, and if the result is negative, the examina-
tion is scheduled for the morning after. Evidence of an ipsi-
lateral carotid stenosis$50% according to NASCET criteria
is the main indication for urgent carotid surgery.
Second-level imaging of neck vessels, such as CT angi-
ography or magnetic resonance angiography, is obtained
when the accuracy of duplex is highly questionable (ie,
hard calciﬁc plaques or high lesions). When there is noagreement between the ﬁrst-level and second-level exami-
nations, carotid angiography is performed as the third-
level assessment.
A preoperative assessment is immediately performed by
an anesthesiologist. Timing of surgery is then discussed
among the surgeon, neurologist, and anesthesiologist,
with the aim of performing CEA as soon as possible after
the diagnosis, given that appropriate medical treatment is
started (ie, control of arterial hypertension).
Patients who are not already taking antiplatelet drugs
are given acetylsalicylic acid (300 mg orally or 250 mg
intravenously in case of difﬁcult oral intake). Uncontrolled
systolic hypertension (systolic BP $220 mm Hg) or
moderate diastolic hypertension (diastolic BP 100-
140 mm Hg) is treated by an intravenous infusion of labe-
talol (20-300 mg) and urapidil (50-250 mg). Uncontrolled
severe diastolic hypertension (diastolic BP >140 mm Hg)
is treated with slow infusion of sodium nitroprusside
(0.5 mg/kg/min). Patients taking oral anticoagulants are
reversed through vitamin K and preoperatively switched
to low-molecular-weight heparin. Carotid surgery is
deferred until normalization of coagulation tests.
Surgery is scheduled as soon as possible, often before
admission to the ward. When necessary, an emergency
operating room (OR) is used, and an emergency anesthesi-
ologist is called. Especially in recent years, patients with
TIAs with a low ABCD2 score admitted during the
evening or night are deferred until the next morning if
an elective OR is available. Sometimes this option is also
chosen if the emergency OR is expected to be unavailable
for a long time. In these cases, the patient is admitted to
the Stroke Unit.
None of our patients urgently admitted for a neurologic
deﬁcit are deferred or postponed on purpose until a prede-
termined period of time.
Operative procedure. Seven surgeons performed 193
CEAs during the 10-year period. Surgical technique and
periprocedural and intraoperative monitoring were the
same for patients who underwent urgent and nonurgent
operations.
Routine intraoperative physiologic monitoring in-
cluded pulse oximetry, electrocardiogram, and invasive
BP measurement. In case of general anesthesia, cortical
blood oxygen saturation was continuously monitored
through an INVOS Cerebral Oximeter (Somanetics,
Troy, Mich). In case of locoregional anesthesia, motor
and cognitive functions were clinically monitored. A
temporary indwelling shunt was selectively used in case of
persistent $20% fall of cortical oxygenation at INVOS
under general anesthesia, whereas for locoregional anes-
thesia, when motor or cognitive deterioration appeared.
Heparin (5000 IU) was administered intravenously before
cross-clamping, and its efﬁcacy was assessed by the acti-
vated clotting time test (target $220 seconds).
The surgical technique consisted of patch angioplasty
in most patients, and eversion endarterectomy was chosen
when the carotid artery was redundant or kinked. Routine
intraoperative carotid duplex scanning was performed in all
Table I. Patient groups by clinical presentation
Group Presentation Patients, No.
Total 193
Group 1 Acute neurologic deﬁcit 90
Group 1A TIA 27
Single 16
Recurrent 11
Group 1B Stroke 52
Minor 33
Moderate 19
Group 1C SIE 11
Group 2 Nonrecent TIA or stroke 103
Group 2A TIA 65
Group 2B Stroke 38
SIE, Stroke in evolution; TIA, transient ischemic attack.
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and to detect residual end-plaque frond/ﬂap or other
defects. At the end of the procedure, heparin was selec-
tively reversed after a second activated clotting time test.
During the postoperative period, patients who under-
went urgent operations were admitted to the Stroke
Unit, where evolution of their clinical status was strictly
monitored: any deterioration of a previous deﬁcit or
appearance of a new deﬁcit was recorded and quantiﬁed
through NIHSS variation and immediately investigated
through bCT. In patients with no postoperative deteriora-
tion, bCT was routinely repeated 48 to 72 hours after
surgery.
Postoperative hospitalization of elective CEA patients
was conducted in a vascular surgery ward. Neurologic eval-
uation was routinely repeated after surgery, but bCT was
not routinely repeated.
After discharge, all patients were scheduled for a duplex
scan at 6 and 12 months and yearly thereafter. The pres-
ence of a >50% contralateral carotid stenosis was some-
times the reason for a shorter interval after the ﬁrst year.
A vascular neurologist performed a clinical follow-up of
all urgently operated-on patients at 6 and 12 months and
as needed by each patient thereafter.
Statistical analysis. Results are expressed by means
and standard deviations or by median and interquartile
range (IQR) as appropriate. Statistical analysis was per-
formed using the Pearson test and, when appropriate, the
Fisher exact test for nominal variables. Comparison of
continuous measures was performed using the Student t-
test or, when appropriate, the Wilcoxon signed rank test.
Signiﬁcance was assumed at P < .05.
RESULTS
From January 2002 to January 2012, 193 symptomatic
patients were treated for symptomatic carotid disease
(Table I). Ninety patients were urgently operated on after
admission to our emergency department (group 1).
Among these 90 patients, clinical presentation was TIA
in 27 (30%, group 1A), stable stroke in 52 (57.8%, group
1B), and SIE in 11 (12.2%, group 1C).In the same period of time, 103 patients (group 2)
underwent elective surgery because of a nonrecent CVA
(Table I); 65 (63.1%) had sustained a TIA, and 38 (36.9%)
were diagnosed with an ischemic stroke (Table II). This
difference between group 1 and group 2 in the proportion
of transient symptoms was highly signiﬁcant (P ¼ .0001).
Study population was composed of 129 men (66.8%)
and 64 women (33.2%), and their mean age at presentation
was 71 years (range, 37-92 years). The two groups did not
signiﬁcantly differ in age and sex (Table II). The prevalence
of classic risk factors for CVAs, such as systemic hyperten-
sion, smoking habit, and dyslipidemia, was similar across
groups. Group 1 showed a signiﬁcantly higher proportion
of patients with vascular comorbidities, such as a history
of coronary heart disease (30% vs 13.5%; P ¼ .01), a history
of peripheral artery disease (15.5% vs 6.8%; P ¼ .4), and
a trend for a higher prevalence of diabetes mellitus
(27.7% vs 18.4%; P ¼ .1).
We always performed an urgent bCT in group 1
patients, and ischemic lesions were recorded in 22
(24.4%) before surgery. Magnetic resonance imaging with
diffusion-weighted imaging sequence was also performed
in eight patients to conﬁrm CT results. Group 2 patients
also had a preoperative bCT, which was repeated only in
seven patients where preoperative symptoms worsened or
new symptoms developed after surgery (Table III).
In 131 patients (67.9%), the sole diagnostic imaging
modality was carotid duplex. Second-level imaging of
carotid arteries was necessary for 56 (29%), comprising
48 CT angiographies and eight magnetic resonance angi-
ographies. Only six (3.1%) underwent an angiogram. The
proportion of second-level imaging was higher for group
2 (20% vs 53.4%; P ¼ .001).
We then looked speciﬁcally at the timing of our oper-
ations in group 1 patients. The median time from symptom
onset to surgery was 48 hours (IQR, 17-113 hours;
Table III); all 90 patients were diagnosed with carotid
stenosis in the acute phase of a CVA and underwent oper-
ations as soon as possible. Median time from symptoms to
observation was 4 hours (IQR, 2-24 hours) and from
observation to surgery was 18 hours (IQR, 8-64 hours).
A Vascu-Guard bovine pericardium patch (Synovis, St.
Paul, Minn) was used to close the arteriotomy in 150
patients (77.2%), direct closure of the arteriotomy was
chosen in 26 (11.1%), and eversion CEA was the technique
for 24 (10.3%). One procedure from group 1 was an
urgent standard embolectomy with Fogarty catheter. This
patient had embolic carotid bulb occlusion with patency
of the distal vessel. After surgery, he was found to have
a deep vein thrombosis and a patent foramen ovale.
Mean duration of CEA was 119 minutes (range, 40-
190 minutes), with a mean carotid clamping of 40 minutes
(range, 14-100 minutes).
On the basis of intraoperative monitoring, 14 patients
(7.2%) required shunting. An intraoperative ultrasound
control after suture of the arteriotomy is a standard proce-
dure in our division and was performed during all interven-
tions. This led to three surgical revisions (1.5%) because of
Table II. Comparison of urgently and nonurgently operated-on patients: Demographics, clinical presentation, treatment,
and outcomes
Variablesa Total (N ¼ 193) U-CEA (n ¼ 90) E-CEA (n ¼ 103) P
Demographics
Age, years 71 (37-92) 70 (37-89) 72 (47-92) .6
Male sex 129 (66.8) 64 (71.1) 65 (63.1) .2
Hypertension 167 (86.5) 75 (83.3) 92 (89.3) .3
Smoking 115 (59.6) 56 (62.2) 59 (57.2) .5
Dyslipidemia 98 (50.8) 48 (53.3) 50 (48.5) .5
Diabetes 44 (22.8) 25 (27.7) 19 (18.4) .1
Coronary artery disease 41 (21.2) 27 (30.0) 14 (13.5) .007
Peripheral artery disease 21 (10.9) 14 (15.5) 7 (6.8) .06
Presentation
Stroke 101 (52.3) 63 (70.0) 38 (36.9) .0001
TIA 92 (47.7) 27 (30.0) 65 (63.1)
Surgery
Duration, minutes 119 (40-190) 119 (60-180) 119 (40-190) .5
Clamp time, minutes 40 (14-100) 40 (16-80) 39 (14-100) .5
Patch angioplasty 150 (77.7) 71 (78.8) 79 (76.6) .6
Shunting 14 (7.2) 5 (5.6) 9 (8.7) .4
30-day outcomes
Stroke 10 (5.2) 6 (6.6) 4 (3.9) .5
Mortality 5 (2.6) 4 (4.4) 1 (0.9) .1
Stroke/mortality 11 (5.7) 7 (7.7) 4 (3.9) .3
E-CEA, Elective carotid endarterectomy; TIA, transient ischemic attack; U-CEA, urgent carotid endarterectomy.
aCategoric data are shown as number (%) and continuous data as mean (range).
Table III. Comparison of timing of surgery, radiologic ﬁndings, and outcomes of urgently operated-on patients (group 1)
by clinical presentation
Variablesa Total (N ¼ 90) TIA (n ¼ 27) Stroke (n ¼ 52) SIE (n ¼ 11) P
Timing of surgery
Onset-surgery, hours 47.5 (17-113) 29 (18-95) 49.5 (16-117) 53 (17-168) .7
Preoperative
Ischemic lesion at bCT/MRI 27 (30.0) 0 24 (46.1) 3 (27.3)
Postoperative
New ischemic lesion at bCT 35 (38.9) 0 27 (51.9) 8 (72.7)
Hemorrhagic lesion at bCT 1 (1.1) 0 1 (1.9) 0
30-day outcomes
Stroke 6 (6.6) 0 (0) 3 (5.8) 3 (27.3) .008
Mortality 4 (4.4) 1 (3.4) 1 (1.9) 2 (18.2) .05
Stroke/mortality 7 (7.7) 1 (3.4) 3 (5.8) 3 (27.3) .03
bCT, Brain computed tomography; IQR, interquartile range; MRI, magnetic resonance imaging; SIE, stroke in evolution; TIA, transient ischemic attack.
aCategoric data are shown as number (%) and continuous data as median (IQR).
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1 (1.1%) and two in group 2 (1.9%).
Outcomes and clinical presentation. Overall, ten 30-
day postoperative strokes (5.2%) were recorded, and the 30-
day mortality rate was 2.6% (ﬁve patients). The combined
death/stroke rate was 5.7% (11 patients). Six of the 90
urgent CEAs were complicated by periprocedural stroke
(6.6%), and four deaths (4.4%) were recorded. Four post-
operative strokes were recorded among the 103 elective
CEAs (3.9%), with only one death (0.9%), which was caused
by postoperative hyperperfusion cerebral edema (Table II).
The postoperative stroke rate of urgently operated-on
patients was signiﬁcantly correlated with clinical presenta-
tion (Table III). None of the 27 patients with a TIA(group 1A) had clinical or radiologic signs of brain ischemia.
Among 52 patients from group 1B (mild to moderate
stroke), three (5.8%) sustained a postoperative stroke,
namely, one fatal intracranial hemorrhage on postoperative
day 4 and two thromboembolic lesions (postoperative
appearance of multiple ipsilateral ischemic lesions on
bCT) associated with signiﬁcant NIHSS deterioration
(þ5 points in both patients). Group 1C patients had the
highest rate of complications, with three of 11 patients
(27.3%) with a postoperative stroke: two with a fatal massive
hemispheric ischemic lesion with cerebral edema and herni-
ation and one thromboembolic stroke associated with
signiﬁcant NIHSS deterioration (Table IV). Mortality was
similarly unevenly distributed: one death in 27 group 1A
Table IV. Detailed description of postoperative neurologic complications within urgently operated-on patients (group 1)
Patient sex, years Group NIHSS Timing of surgery Postoperative bCT Time of onset Outcome
F, 68 1C 8-12 168 hours Vast hemispheric infarction with brain edema POD 1 Death
M, 77 1B 5 240 hours New discrete ischemic lesion OD NIHSS 10 (þ5)
M, 51 1C 2-6 40 hours Extension of previous ischemic lesion POD 3 NIHSS 15 (þ9)
M, 68 1B 3 102 hours Intraparenchymal hemorrhage POD 4 Death
M, 72 1C 6-13 56 hours Vast hemispheric infarction with brain edema POD 2 Death
F, 71 1B 2 34 hours 2 new ischemic lesions OD NIHSS 7 (þ5)
bCT, Brain computed tomography; F, female; M, male; NIHSS, National Institutes of Health Stroke Scale; OD, operative day; POD, postoperative day.
Table V. Comparison of outcomes of urgently operated-










Group 1 (n ¼ 90) 45 45
30-day stroke 2 (4.4) 4 (8.8) .6
30-day stroke/
mortality
2 (4.4) 5 (11.1) .4
Group 1A (n ¼ 27) 16 11
30-day stroke 0 (0) 0 (0) 1
30-day stroke/
mortality
0 (0) 1 (9) .4
Group 1B (n ¼ 52) 25 27
30-day stroke 1 (4) 2 (7.4) .9
30-day stroke/
mortality
1 (4) 2 (7.4) .9
Group 1C (n ¼ 11) 4 7
30-day stroke 1 (25.0) 2 (28.6) .7
30-day stroke/
mortality
1 (25.0) 2 (28.6) .7
Fig. Distribution of National Institutes of Health Stroke Scale
(NIHSS) variation after carotid surgery in group 1B patients.
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among 52 in group 1B (1.9%), and 2 of 11 in group 1C
(18.2%).
Combined mortality/stroke rate was 7.7% (seven of
90) for group 1, 3.7% (one of 27) for group 1A, 5.7%
(three of 52) for group 1B, and 27.3% (three of 11) for
group 1C, respectively (Table III). SIE patients had
a signiﬁcantly higher 30-day postoperative stroke rate
(P ¼ .008), 30-day mortality rate (P ¼ .05), and 30-day
combined mortality/stroke rate (P ¼ .03) than patients
presenting after TIA or stable stroke.
Outcomes and timing of surgery. Further analysis of
outcomes of group 1 patients was performed after stratiﬁ-
cation by delay of surgery from onset of symptoms
(Table V). We used the median timing of surgery within
this population as a reference: outcomes of patients oper-
ated on#48 hours from onset of symptoms (median delay,
17 hours; IQR, 9-26 hours) were compared with outcomes
of patients operated on after >48 hours (median delay,
110 hours; IQR, 55-210 hours). CEAs performed
#48 hours resulted in two postoperative strokes, whereas
CEAs performed >48 hours resulted in four postoperative
strokes (4.4% vs 8.8%; P ¼ .6). This difference, although
not statistically signiﬁcant, was conﬁrmed in group 1B (4%vs 7.4% postoperative stroke; P ¼ .9) and in group 1C
(14.3% vs 50% postoperative stroke; P ¼ .4).
NIHSS variation in group 1B patients. Group 1B
patients (minor to moderate stroke) had a median NIHSS
of 4 (IQR, 2-6.2) on admission and of 2 (IQR, 1-4) at
discharge (P < .001). Median absolute NIHSS variation
was2 (IQR, 0 to4), whereas its median relative decrease
was50% (IQR, 25% to75%). NIHSS improved by$4
points in 13 of 52 patients (25%), by<4 points in 28 patients
(54%), and showed no improvement in the remaining nine
(17%). In two patients (4%), we observed persistent NIHSS
deterioration; in both patients, the NIHSS gained 5 points:
from 5 to 10 in one and from 2 to 7 in the other (Fig).
Absolute value of NIHSS variation was signiﬁcantly
higher for patients with moderate stroke than for patients
with minor stroke (P ¼ .001). The former subgroup had
a median score of 8 (IQR, 5-11) at presentation and
a median score of 5 (IQR, 2-8) at discharge, with a median
variation of 3 (IQR, 0 to 5). The median NIHSS in the
latter subgroup was 3 (IQR, 2-3.5) on admission and 1
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(IQR, 0.75 to 2).
DISCUSSION
This study is the result of a retrospective analysis of data
from prospectively identiﬁed patients who were treated
with urgent CEA in our hospital from 2002 to 2012. Per-
forming CEA in an urgent setting requires strong clinical
and logistic collaboration between vascular surgeons and
neurologists, and this multidisciplinary collaboration
started in our center in 2002. In this series, the median
delay of surgery from onset of symptoms was 48 hours
(to our knowledge, one of the shortest in the literature),
and we regard this as a sign of our efforts to avoid any
unnecessary delay. Besides, the number of urgently
operated-on patients was very close to that of electively
operated-on patients (90 vs 103), and in the future, this
proportion will possibly reverse because all acutely ill
patients are offered urgent treatment whenever possible.
Our diagnostic ﬂow chart is very simple and was
applied, regardless of different clinical presentation, to
patients with TIAs, strokes with minor to moderate neuro-
logic deﬁcit, and even in patients with rapidly deteriorating
brain infarctions. Beyond obvious exclusion of patients
with hemorrhage and major neurologic disability, popula-
tion selection was minimal compared with other studies.
Brain imaging was done by plain CT in all patients, with
complementary use of diffusion-weighted magnetic reso-
nance imaging in a small minority of patients.
The surgical protocol is exactly the same as with elec-
tive CEA: cerebral monitoring by near-infrared spectros-
copy and intraoperative control by ultrasound imaging
are both easily managed by the operating surgeon, without
the need of specialized personnel (ie, electrophysiologist
for electroencephalogram or radiology technician for
angiography).
Performing urgent CEA on this “unselected” popula-
tion yielded acceptable 30-day rates of stroke, death, and
combined stroke/death. Not surprisingly, a higher rate of
postoperative complications and death resulted from com-
parison with patients operated on for a nonacute disease,
although the difference was not statistically signiﬁcant.
These data have already been reported18,19 but may be
misleading if taken alone: a bigger proportion of patients
presenting with stroke and a higher prevalence of vascular
comorbidities in the group of urgent CEAmay at least partly
account for worse outcomes and make the two populations
not perfectly comparable.
Within group 1, results of urgent surgery were not
uniform across clinical subgroups. The postoperative
course was neurologically uneventful for patients present-
ing with a single or recurrent TIA (group 1A). An aggres-
sive surgical approach is safe in this population and is of
particular value when the risk of recurrence is high, such
as in patients with an ABCD2 score $4.
Results were particularly poor in the patients present-
ing with SIE (group 1C). This is historically the clinical
presentation associated with the worst postoperativeoutcomes,20 although the natural history of SIE does not
indicate medical treatment as a safe and effective alternative
to surgery. Leseche et al21 published a report in 2012 doc-
umenting excellent outcome of CEA performed in the
acute phase of SIE (median delay of 6 days from onset
of symptoms to surgery). Their experience was quite
different from ours and from most series. In the light of
our results, we have gradually shifted to a more conserva-
tive approach.
Group 1B is the most interesting because it was
composed of a number of urgently operated-on patients
with stable stroke who showed a low rate of postoperative
complications. This was the less predictable population
because there is a striking lack of published data on this
speciﬁc issue. Besides the relatively low rate of postoperative
strokes, we observed that a very high percentage of patients
(79%) experienced postoperative NIHSS improvement, and
we consider it a promising result. We do not know if the
beneﬁcial effects associated with early intervention should
be attributed to prevention of ischemic recurrence (possible
episodes of plaque re-embolization) or precocious blood
ﬂow restoration on a still vital ischemic brain tissue (brain
penumbra), with prevention of perilesional edema (a mech-
anism of blood ﬂow limitation itself), or even to both.
The only study on U-CEA reporting the outcome of
postoperative neurologic improvement of minor and
moderate stroke was published by Capoccia et al.22 Our
data support some of their conclusion: minimizing the
time of intervention reduces the risk of recurrence and
can be considered safe even for patients with an NIHSS
score >8 and #15. Overall, we did not ﬁnd a statistical
correlation between the timing of CEA and the rate of
postoperative neurologic complications. Using our median
time interval from symptoms to surgery as a threshold for
comparison, we did not ﬁnd a higher risk of stroke or death
in the patients who received surgery #48 hours from onset
of symptoms.
These data are in contrast with those reported by
Stromberg et al23 in a recent analysis of the Swedish
Vascular Registry. After stratifying for timing of surgery
for >2500 symptomatic patients who underwent CEA in
Sweden, they concluded that CEA performed <48 hours
from onset of symptoms has a higher rate of complications
than if the procedure is delayed by >48 hours (combined
stroke/death rate of 11.5% vs 3.6%-5.7%).
We believe that urgency alone does not increase risks of
postoperative complications of CEA and that, as stated by
Naylor24 in a letter to Stromberg et al, high risks deriving
from a surgical procedure should not be considered
without comparison with the natural history of the speciﬁc
CVA during the hyperacute period. This is not possible
unless a clinical stratiﬁcation is adopted when reporting
the outcome of urgent CEA.
CONCLUSIONS
Our results with U-CEA conﬁrm that this population
has a higher risk proﬁle compared with elective CEA.
There is a correlation between the type of acute
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446 Barbetta et al February 2014presentation and perioperative risk. U-CEA was safe when
performed on patients presenting with TIA. In our
opinion, the nonelective procedure should be available at
least in case of an ABCD2 score$4. An acceptable compli-
cation rate was achieved for patients with minor to
moderate strokes, and we believe it is justiﬁed by the signif-
icant risk of early ischemic recurrence in the natural history
of the disease. Treatment in the hyperacute phase can also
improve neurologic symptoms. We had the poorest
outcomes on patients presenting with SIE: U-CEA on
these patients should be offered with extreme caution,
although we are aware that a conservative treatment may
not grant a better prognosis.
The authors would like to thank Daniele Bissacco,
MD, Vincenzo Catanese, and Sara Di Gregorio for their
precious help extracting the data from charts.
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